And

are now a part of the new and improved

search Created with Sketch.
search Created with Sketch.

Advertisement

Dermwire News

News | July 1, 2020

Soliton Seeks 510 Clearance for RAP Anti-Cellulite Device

Soliton, Inc. filed for 510(k) premarket clearance with the U.S. Food and Drug Administration (FDA) of its second-generation Rapid Acoustic Pulse (RAP) device for the reduction in the appearance of cellulite. The RAP device was...

Read More

News | June 30, 2020

ISD Survey: Climate Change Is A Real Threat to Skin Health

The vast majority of dermatologists (95.6 percent) believe climate change is occurring and 88.6 percent indicated that climate change will impact the incidence of skin diseases in their areas, according to an online survey was...

Read More

News | June 30, 2020

AOBiome Initiates Phase 2b Clinical Trial of B244 in Adults with AD

AOBiome Therapeutics, Inc. is initiating a Phase 2b clinical trial of its lead product candidate, B244, in pruritus associated with atopic dermatitis. B244 is a first-in-class, topical formulation of beneficial ammonia oxidizing bacteria...

Read More

News | June 29, 2020

TOOsonix A/S Rolls Out System ONE-M for Aesthetic Treatments

TOOsonix A/S is launching its CE-marked System ONE-M for color-independent tattoo removal, solar lentigines, spider veins, angiomas, telangiectasia and other aesthetic conditions. System ONE-M is a focused ultrasound device operating at...

Read More

News | June 29, 2020

Aerolase Appoints Industry Vet Didier Leclercq to Leadership Team

Didier Leclercq is Aerolase’s new Vice President of Global Market Development.  Prior to his role as Managing Director of the SHIELD innovation center of Nestlé Skin Health/Galderma, Mr. Leclercq ran Q-Med once it was...

Read More

Advertisement

The Latest News

Advertisement

View more